Anthony Buisson1,2,3, Wing Yan Mak1,4, Michael J Andersen1, Donald Lei1, Joel Pekow1, Russell D Cohen1, Stacy A Kahn5, Bruno Pereira6, David T Rubin1. 1. University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA. 2. Université Clermont Auvergne, Inserm, CHU Clermont-Ferrand, 3iHP, Service d'Hépato-Gastro Entérologie, Clermont-Ferrand, France. 3. Department of Medicine Université Clermont Auvergne, 3iHP, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France. 4. Queen Elizabeth Hospital, Hong Kong. 5. Inflammatory Bowel Disease Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. 6. Université Clermont Auvergne, CHU Clermont-Ferrand, DRCI, Unité de Biostatistiques, Clermont-Ferrand, France.
Abstract
BACKGROUND: As the reliability of fecal calprotectin (Fcal) remains debatable to detect endoscopic ulcerations in patients with pure ileal Crohn's disease (CD), we aimed to compare its performances with those observed in patients with colonic or ileocolonic location. METHODS: Using a prospectively maintained database, we analyzed 123 CD patients with Fcal measurement and ileocolonoscopy performed within 1 month with no therapeutic intervention during this interval. Receiver operating characterstic curves (ROC) were used to determine the best Fcal threshold to detect endoscopic ulcerations, taking into account the clinical relevance and usual recommended indices. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were presented with 95% confidence intervals. RESULTS: The mean Fcal level was significantly higher in patients with endoscopic ulcerations in the L1 group (P = 0.025) and the L2-L3 group (P < 0.001). Using ROC curves, Fcal >200 µg/g and Fcal >250 µg/g were the best thresholds to detect endoscopic ulcerations in the L1 group (sensitivity = 75.0, 95% CI, 47.6-92.7; specificity = 87.5, 95% CI, 67.6-97.3; PPV = 80.0, 95% CI, 51.9-95.7; and NPV = 84.0; 95% CI, 63.9-95.5) and in the L2-L3 group (sensitivity = 84.1 95% CI, 69.9-93.4; specificity = 74.4, 95% CI, 57.9-87.0; PPV = 78.7, 95% CI, 64.3-89.3, and NPV = 80.6, 95% CI, 64.0-91.8), respectively. We compared the AUC between L1 and L2-L3 groups, and no difference was shown (0.89 vs 0.84, respectively, P = 0.46). We also compared 2-by-2 sensitivity, specificity, PPV, NPV, and accuracy and we did not observe any significant difference. CONCLUSION: Fecal calprotectin is highly effective to detect endoscopic ulcerations regardless of CD location but requires a lower cutoff value in patients with pure ileal involvement.
BACKGROUND: As the reliability of fecal calprotectin (Fcal) remains debatable to detect endoscopic ulcerations in patients with pure ileal Crohn's disease (CD), we aimed to compare its performances with those observed in patients with colonic or ileocolonic location. METHODS: Using a prospectively maintained database, we analyzed 123 CD patients with Fcal measurement and ileocolonoscopy performed within 1 month with no therapeutic intervention during this interval. Receiver operating characterstic curves (ROC) were used to determine the best Fcal threshold to detect endoscopic ulcerations, taking into account the clinical relevance and usual recommended indices. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were presented with 95% confidence intervals. RESULTS: The mean Fcal level was significantly higher in patients with endoscopic ulcerations in the L1 group (P = 0.025) and the L2-L3 group (P < 0.001). Using ROC curves, Fcal >200 µg/g and Fcal >250 µg/g were the best thresholds to detect endoscopic ulcerations in the L1 group (sensitivity = 75.0, 95% CI, 47.6-92.7; specificity = 87.5, 95% CI, 67.6-97.3; PPV = 80.0, 95% CI, 51.9-95.7; and NPV = 84.0; 95% CI, 63.9-95.5) and in the L2-L3 group (sensitivity = 84.1 95% CI, 69.9-93.4; specificity = 74.4, 95% CI, 57.9-87.0; PPV = 78.7, 95% CI, 64.3-89.3, and NPV = 80.6, 95% CI, 64.0-91.8), respectively. We compared the AUC between L1 and L2-L3 groups, and no difference was shown (0.89 vs 0.84, respectively, P = 0.46). We also compared 2-by-2 sensitivity, specificity, PPV, NPV, and accuracy and we did not observe any significant difference. CONCLUSION: Fecal calprotectin is highly effective to detect endoscopic ulcerations regardless of CD location but requires a lower cutoff value in patients with pure ileal involvement.
Authors: F Goutorbe; M Goutte; R Minet-Quinard; A-L Boucher; B Pereira; G Bommelaer; A Buisson Journal: J Crohns Colitis Date: 2015-09-07 Impact factor: 9.071
Authors: Krisztina B Gecse; Johannan F Brandse; Sandra van Wilpe; Mark Löwenberg; Cyriel Ponsioen; Gijs van den Brink; Geert D'Haens Journal: Scand J Gastroenterol Date: 2015-01-30 Impact factor: 2.423
Authors: Emily K Wright; Michael A Kamm; Peter De Cruz; Amy L Hamilton; Kathryn J Ritchie; Efrosinia O Krejany; Steven Leach; Alexandra Gorelik; Danny Liew; Lani Prideaux; Ian C Lawrance; Jane M Andrews; Peter A Bampton; Simon L Jakobovits; Timothy H Florin; Peter R Gibson; Henry Debinski; Finlay A Macrae; Douglas Samuel; Ian Kronborg; Graeme Radford-Smith; Warwick Selby; Michael J Johnston; Rodney Woods; P Ross Elliott; Sally J Bell; Steven J Brown; William R Connell; Andrew S Day; Paul V Desmond; Richard B Gearry Journal: Gastroenterology Date: 2015-01-22 Impact factor: 22.682
Authors: Benjamin Pariente; Jean-Yves Mary; Silvio Danese; Yehuda Chowers; Peter De Cruz; Geert D'Haens; Edward V Loftus; Edouard Louis; Julian Panés; Jürgen Schölmerich; Stefan Schreiber; Maurizio Vecchi; Julien Branche; David Bruining; Gionata Fiorino; Matthias Herzog; Michael A Kamm; Amir Klein; Maïté Lewin; Paul Meunier; Ingrid Ordas; Ulrike Strauch; Gian-Eugenio Tontini; Anne-Marie Zagdanski; Cristiana Bonifacio; Jordi Rimola; Maria Nachury; Christophe Leroy; William Sandborn; Jean-Frédéric Colombel; Jacques Cosnes Journal: Gastroenterology Date: 2014-09-21 Impact factor: 22.682